The G34-mutated tumors have been found to rely on the TGFB1 and HAVCR2 (TIM3) pathways for immune evasion [10] indicating that the underlying genetic makeup of the glioma may influence preferential dominant immune-suppressive mechanisms. This evidence concerns the gene HAVCR2 and central nervous system cancer.